Kevin R. Thornal - 01 Aug 2026 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Reporting relationship: Grp Pres-Global Business
Issuer ticker: ZBH
Reported as of: 01 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2026, 16:18:14 UTC
Prior SEC filing: 24 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Kevin Thornal (power of attorney previously filed)

Key filing fact

Kevin R. Thornal filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 04 Aug 2026.

Key facts

This page summarizes Kevin R. Thornal's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Aug 2026, 16:18.

Change

Previous filing in this sequence was filed on 24 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001783992 Primary reporting owner

Thornal Kevin R

Relationship: Grp Pres-Global Business
Address: 345 E. MAIN STREET, WARSAW
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Kevin Thornal (power of attorney previously filed)
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZBH transaction

Common Stock

Options Exercise

Transaction value
Shares: +9,957
Change %
Price: $0.000000^*
Shares after: 9,957
Date: 01 Aug 2026
Ownership: Direct

ZBH transaction

Common Stock

Tax liability

Transaction value
Shares: -4,266
Change %: -43%
Price: $92.68^*
Shares after: 5,691
Date: 01 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZBH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -9,957
Change %: -33%
Price: $0.000000^*
Shares after: 19,913
Date: 01 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,957
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Footnote F2

Each RSU represents a contingent right to receive one share of Company common stock.

Footnote F3

One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.